title: [Should we administer replacement therapy to patients with alpha-1-antitrypsin deficit?].
authors.forename: M
authors.initials: M
authors.lastname: Miravitlles
mesh_terms: D005541:Forced Expiratory Volume; D006801:Humans; D000515:alpha 1-Antitrypsin / Q000627:therapeutic use*; D019896:alpha 1-Antitrypsin Deficiency / Q000188:drug therapy* / Q000503:physiopathology
chemical_list: D000515:alpha 1-Antitrypsin
vernacular_title: Debemos administrar tratamiento sustitutivo a los pacientes con déficit de alfa-1-antitripsina?